Introduction 47
With the availability of the finished human genome sequence and the draft mouse genome 48 sequence, the priority is now the analysis of gene function. Important goals are the 49 determination of the phenotypes of animals that have deficiencies in every gene (Nadeau et 50 al, 2001) and, at another level, determination of the functional significance of naturally 51 occurring DNA sequence variation, most of which is in the form of single nucleotide 52 polymorphisms. For these ambitions to be realised, the efficiency of the generation and 53 analysis of mutants is critical. Mice are the pre-eminent system for experimental mammalian 54 genetics, and various strategies are in place for high-throughput mutagenesis of mice 55 (Zambrowicz et al, 1998; Chen et al, 2000; Munroe et al, 2000; Hrabe de Angelis, 2000; 56 variety of target genes using synthetic oligonucleotides (e.g. Alexeev et al., 1998 Alexeev et al., , 2000 67 Bandyopadhyay et al., 1999; Cole-Strauss et al.,1996; Kren et al., 1997 Kren et al., , 1998 Kren et al., , 1999 68 Tagalakis et al., 2001 ). These studies have been undertaken with the ultimate goal of gene 69 therapy applications, and typically the mutations targeted were reversion mutations. In most 70 of these studies, the effective reagents used were synthetic self-complementary 71 oligonucleotides known as RNA-DNA oligonucleotides (RDOs) 
Materials and Methods 87 Pronuclear microinjection 88
Microinjection was done using standard procedures (Hogan et al, 1994) . C57BL/6 x CBA/Ca 89 F 1 mice were used throughout, apart from CD1 vasectomised males. Females were 90 superovulated with 5IU PMS and 5IU hCG; embryos were recovered in M2 medium and 91 cultured in M16 in 5% CO 2 , under oil. The chimeraplast was dissolved in 10mM Tris-HCl 92 pH8.0, 0.1mM EDTA. One pronucleus of each embryo was microinjected, and any embryo in 93 which the injected pronucleus was not observed to swell was discarded. Following 94 microinjection the embryos were cultured overnight. For assessment of chimeraplast toxicity, 95 mouse, range 18-35); they were transferred to one oviduct of pseudopregnant foster mothers 100 under avertin anaesthesia (Papaioannou & Fox, 1993) . These experiments were performed 101 fully in compliance with current UK legislation. 102
103
Screening for the mutation 104
The region of the mouse ApoE gene that includes the two sites that are most polymorphic in 105 man was amplified by PCR using primers ccgacatggaggatctacgc and gcgaccttgctccaccagag. 106 PCR conditions were 75mM Tris-HCl (pH8.8 at 25ْ C), 20mM (NH 4 ) 2 SO 4 , 0.01% Tween 20, 107 1.5mM MgCl 2 , 0.1mM dNTPs, 10% DMSO, 0.6µM each primer and 0.04u/µl Taq 108 polymerase. Following an initial denaturation for 5 mins at 95ْ C, 36 cycles of 94ْ C, 62ْ C and 109 72ْ C (40 sec each) were performed with a final extension of 8mins at 72ْ C. We sequenced 110 PCR products from this region of the ApoE gene from wild-type mice from our colony, and 111 the sequences obtained corresponded to the published sequence. 112 DNA was prepared from E12.5 embryos by digesting embryo fragments (whole tail) in 100µl 113 of 50mM KCl, 10mM Tris-HCl pH8.3 at 25ْ C 10µg/ml gelatine, 0.045% Igepal CA-630, 114 0.045% Tween 20, 0.5mg/ml proteinase K at 55ْ C overnight. 7µl of the crude lysate was used 115 per 25µl PCR reaction after heat inactivation of the proteinase K. For digestion with HinP1I, 116 7µl of unpurified PCR products were mixed with an equal volume of H 2 O and 1µl of HinP1I 117 (10u/µl) was added. Following overnight digestion, the DNA was run on 20% 118 polyacrylamide gels (Novex) in TBE and stained with SYBR green I. 119 120
Results

121
We selected apolipoprotein E (ApoE) as a test target for targeted mutation in mouse because 122 we had previously achieved high level conversion of human ApoE genomic and cDNA 123 targets in cultured cells and in transgenic mouse tissue (Tagalakis et al, 2001 ). The three 124 common variants of human ApoE are ApoE2, ApoE3 and ApoE4. ApoE3 is the most 125 frequent; the ApoE2 and ApoE4 alleles differ by virtue of single nucleotide polymorphisms 126 that cause amino acid sequence changes. ApoE2 and ApoE4 are risk factors for 127 atherosclerosis and Alzheimer's disease, respectively. We designed a C T transition 128 mutation that would simultaneously generate an RFLP and an R150C change in mouse ApoE 129 protein (figure 1a), creating a SNP that is equivalent to the human ApoE2 SNP. A 130 chimeraplast was synthesised to create this mutation (figure 1b) and was microinjected into 131 the pronuclei of 1-cell mouse embryos. 132
For the production of transgenic mice, the volume of DNA injected into pronuclei is typically 133 about 2x10 -9 ml, and the optimum concentration of DNA is around 2µg/ml; injection of DNA 134 at concentrations above this significantly reduces the frequency of development of mice to 135 term (Brinster et al, 1985) . For a typical transgene of 10kb, this corresponds to about 350 136 molecules of the construct; the chimeraplast is 68nt long, so a 2x10 -9 ml injection would 137 contain about 10 5 molecules. Double stranded DNA ends are recognised as a sign of 138 chromosome damage; depending on the cell type and extent of the damage, the response to 139 such damage may be cell cycle arrest, or apoptosis. To test whether chimeraplasts are toxic to 140 preimplantation embryos we titrated the concentration of chimeraplast injected into pronuclei 141 (0, 0.25, 2.5 and 25µg/ml), and embryos that survived the immediate trauma of injection were 142 cultured for 4 days. Development to normal blastocyst was significantly reduced for embryos 143 injected with buffer or with chimeraplast, but there was no significant difference between the 144 chimeraplast and buffer injected embryos (figure 2). This shows that the major deleterious 145 effects of injection are independent of the injected DNA, and are probably due to physical 146 damage. For subsequent experiments we injected the DNA at 2.5µg/ml. 147
To test for mutagenic activity of the chimeraplast, we injected it into pronuclear mouse eggs, 148 transferred them into oviducts of pseudopregnant foster mothers, and harvested embryos 12 149 days after transfer. A total of 662 eggs were injected, 420 of which developed to 2-cells and 150 were transferred. 139 embryos were recovered at E12.5; DNA was extracted from each 151 embryo, amplified and digested with HinP1I (figure 1c). None of the embryos gave the 152 diagnostic 68bp fragment, and in other respects the restriction patterns were exactly as 153 predicted (e.g. figure 3 ). 154
155
Discusssion 156
All of the vasectomised males used to generate the recipients were confirmed to be sterile by 157 test matings, some of the embryo recipients were carrying very large numbers of foetuses (up 158 to 17), and some recipients were not pregnant. In mice, embryos do not move from one 159 uterine horn to the other. The embryo transfers were unilateral, and every foetus recovered 160 was in the ipsilateral uterine horn; there was no sign of implantation in the contralateral 161 uterine horns. For these reasons we are confident that all of the recovered foetuses werederived from the eggs that had been injected and transferred, and were not from accidental 163 fertile matings. to the cell nucleus, degradation, toxicity, poor reagent quality and differential accessibility of 168 different target genes. We circumvented many of these concerns: the ApoE gene was chosen 169 because the human homologue has been successfully targeted; direct microinjection 170 eliminates delivery problems as >10 5 molecules were injected per embryo; the chimeraplast 171 gave a discrete band and showed no signs of degradation by gel electrophoresis (figure 4); 172 and finally, the rate of development to blastocyst and to E12.5 of eggs microinjected with 173 chimeraplast was incompatible with a toxicity effect. 174
The reason for our failure to obtain targeted conversions is not clear. We believe that it is not 175 feasible to inject much more chimeraplast DNA without incurring significant 176 postimplantation embryo losses. It has been proposed that chimeraplast activity is dependent 177 on mismatch repair mechanisms. It is possible that preimplantation embryos lack the 178 necessary mismatch repair activity; e.g. 1-to 4-cell stage rat embryos appear not to express 179 
Design of the mutation.
The wild-type DNA and peptide sequence are shown. The target codon is shown in blue, and the targeted DNA sequence alteration is indicated in red; similarly the wild-type and mutant amino acids are shown. To test for successful mutation, we made use of the HinP1I restriction site (underlined) that overlaps the target codon; the wild-type sequence possesses a restriction site; the mutation was designed to destroy this site.
B:
Structure of the chimeraplast. The sequence that is homologous to the mouse ApoE target is shown in blue, with the bases mismatched with the target (and corresponding to the intended sequence change) shown in red; DNA residues are shown in UPPERCASE, 2'O-Me-RNA residues are shown in lowercase; the GC clamp and T residues of the hairpin loops are shown in black.
C: PCR-RFLP analysis.
The complete sequence of the wild-type PCR product is shown, with the targets of the PCR primers underlined, HinP1I sites are double underlined, and the target nucleotide is shown in red. The diagnostic restriction site is flanked by sites 33bp upstream and 35bp downstream. The wild-type allele is predicted to give fragments of 87, 35, 33, 30, 24, 20, 9, 7 and 6bp in length; mutation would cause loss of the 35 and 33bp fragments and a new 68bp fragment. Survival of embryos following injection of the chimeraplast.
Pronuclear mouse embryos were injected with chimeraplast at 0.25, 2.5 or 25 ng/µl, or with buffer alone; the embryos were cultured overnight. The following day, the lysed embryos were discarded, and the remaining 2-cell embryos were transferred to fresh medium (only 1/294 embryos had failed to divide). Control uninjected 2-cell embryos were also transferred to fresh medium. Following a further 3 days in culture, the normal blastocysts were counted. Chi-squared analysis shows that injections of buffer or 2.5µg/ml chimeraplast increased the frequency of abnormal development significantly (P<0.001; χ 2 =40.336, 1d.f. and P<0.001; χ 2 =53.811, 1d.f., respectively); the rates of normal development of chimeraplast-injected and control buffer-injected eggs were indistinguishable (for 2.5µg/ml chimeraplast, P=0.361; χ Intactness of the chimeraplast.
The chimeraplast was run on a 15% polyacrylamide gel and stained with ethidium bromide. The bulk of the material migrated in a discrete band; the higher molecular weight smear is typical of chimeraplasts and is probably caused by intermolecular base pairing.
